August 13, 2009 5:15 PM
- Text
Gilead Axes 139 Jobs in Colorado; CVT Reps Get Culture Shock
(MoneyWatch) Gilead is laying off 66 people as it closes its Colorado offices to consolidate its operations in California, In-Pharma Technologist reports.
Gilead "hopes to relocate 73 of the 139 staff" that work in Colorado, but the company is consolidating in California, so unless all 73 decide to up sticks the actual amount of jobs lost will be greater. The cuts will be affected by New Year, so merry Xmas, Gilead-ites!
The move should not be a surprise. Gilead just acquired CV Therapeutics. In addition to the usual redundancies and overlap, Gilead is the company that gains the most revenues on the least resources invested. One presumes management has no intention of letting its operations get fat just because they bought someone out.
CVT reps are just figuring out that Gilead has a very different corporate culture than what they're used to, according to this Cafe Pharma thread titled, "CVT rep here, 'This Sucks."
And the Gilead people on this thread seem to be taking a fair amount of pleasure in giving their CVT brethren as hostile a welcome as possible ...
Gilead "hopes to relocate 73 of the 139 staff" that work in Colorado, but the company is consolidating in California, so unless all 73 decide to up sticks the actual amount of jobs lost will be greater. The cuts will be affected by New Year, so merry Xmas, Gilead-ites!
The move should not be a surprise. Gilead just acquired CV Therapeutics. In addition to the usual redundancies and overlap, Gilead is the company that gains the most revenues on the least resources invested. One presumes management has no intention of letting its operations get fat just because they bought someone out.CVT reps are just figuring out that Gilead has a very different corporate culture than what they're used to, according to this Cafe Pharma thread titled, "CVT rep here, 'This Sucks."
And the Gilead people on this thread seem to be taking a fair amount of pleasure in giving their CVT brethren as hostile a welcome as possible ...
- See BNET's previous coverage of Gilead:
- Ranking of 20 Drug Companies Shows Sales Force Effectiveness Reaching Plateau
- Gilead Q2 Mystery: Purchase of Less-Efficient CVT Made It a More Efficient Company
- Ranking of 20 Drug Companies by Sales Force Effectiveness Shows Improvement in Q1
- Gilead Q1: Company Is Recession Resistant But Not Lawsuit Resistant
- Gilead Whistleblower Suit: A Bullet Dodged
- With New CV Drugs, Gilead Tests Its Commitment to Efficiency
- Gilead Executive Pay: Modest Raises for Outstanding Performance
- Gilead Deal Gives CV Therapeutics CEO $8.4 Million Payday Despite Lack of Profits
- Gilead's FDA Warning Letter Contains Lesson About the Internet
- Ranking of 20 Drug Companies' Sales Forces Shows Productivity Flat or Declining
Latest Now in MoneyWatch
- Ohio unemployment hits 3-year-low
- Jill on Money: Retirement investing, allocation, long term care
- Could "web-lining" be dangerous?
- Insurers respond cautiously to contraceptive plan
- Judge: Legally, breastfeeding not related to pregnancy
- Budget deficit drops to $27 billion in January
- Why the Powerball Jackpot is part of my investment strategy
- Is the new VW Beetle diesel worth the money?
- Consumer sentiment highlights risks to recovery
- Valentine blues? 10 best cities to be single
- December trade deficit widens to $48.8 billion
- Alcatel-Lucent returns to profit in 2011
- 6 things never to say in a performance review
- $26B mortgage deal: Who gets the money?
- Friendly's CEO steps down
- Quarterly loss hits $3.3B at Postal Service
- Greeks rail against cuts as EU demands more
Latest CBS News Headlines
on Facebook
on CBS News
- Boeing says it's frustrated with Dreamliner glitch
- Officials: Gaza man killed in Israeli airstrike
- Gunmen kill provincial judge, child in Afghanistan
- Boeing says it's frustrated with Dreamliner glitch
on Facebook
- Whitney Houston 1963-2012
- Adele sings a cappella for Anderson Cooper
- "Phantom" star sings on "CBS This Morning: Saturday"
on CBS News






